Product NDC: | 37205-273 |
Proprietary Name: | LEADER TRIPLE ANTIBIOTIC |
Non Proprietary Name: | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE |
Active Ingredient(s): | 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g & nbsp; BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 37205-273 |
Labeler Name: | CARDINAL HEALTH |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120301 |
Package NDC: | 37205-273-10 |
Package Description: | 1 TUBE in 1 CARTON (37205-273-10) > 28 g in 1 TUBE |
NDC Code | 37205-273-10 |
Proprietary Name | LEADER TRIPLE ANTIBIOTIC |
Package Description | 1 TUBE in 1 CARTON (37205-273-10) > 28 g in 1 TUBE |
Product NDC | 37205-273 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20120301 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | CARDINAL HEALTH |
Substance Name | BACITRACIN; NEOMYCIN; POLYMYXIN B SULFATE |
Strength Number | 400; 3.5; 5000 |
Strength Unit | [iU]/g; mg/g; [iU]/g |
Pharmaceutical Classes |